• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用干细胞治疗视网膜疾病的临床研究:最新进展

Clinical studies using stem cells for treatment of retinal diseases: state of the art.

作者信息

Cotrim Carina Costa, Jorge Rodrigo, Oliveira Maria Carolina de, Pieroni Fabiano, Messias André M Vieira, Siqueira Rubens Camargo

机构信息

Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine of Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Department of Internal Medicine Faculty of Medicine of Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

出版信息

Arq Bras Oftalmol. 2020 Mar-Apr;83(2):160-167. doi: 10.5935/0004-2749.20200037.

DOI:10.5935/0004-2749.20200037
PMID:32159599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11826738/
Abstract

Degenerative retinal diseases such as retinitis pigmentosa, Stargardt's macular dystrophy, and age-related macular degeneration are characterized by irreversible loss of vision due to direct or indirect photoreceptor damage. No effective treatments exist, but stem cell studies have shown promising results. Our aim with this review was to describe the types of stem cells that are under study, their effects, and the main clinical trials involving them.

摘要

诸如色素性视网膜炎、斯塔加特黄斑营养不良和年龄相关性黄斑变性等退行性视网膜疾病的特征是由于直接或间接的光感受器损伤导致不可逆的视力丧失。目前尚无有效的治疗方法,但干细胞研究已显示出有希望的结果。我们撰写这篇综述的目的是描述正在研究的干细胞类型、它们的作用以及涉及它们的主要临床试验。

相似文献

1
Clinical studies using stem cells for treatment of retinal diseases: state of the art.使用干细胞治疗视网膜疾病的临床研究:最新进展
Arq Bras Oftalmol. 2020 Mar-Apr;83(2):160-167. doi: 10.5935/0004-2749.20200037.
2
Stemming retinal regeneration with pluripotent stem cells.利用多能干细胞实现视网膜再生。
Prog Retin Eye Res. 2019 Mar;69:38-56. doi: 10.1016/j.preteyeres.2018.11.003. Epub 2018 Nov 9.
3
Organoid technology for retinal repair.用于视网膜修复的类器官技术。
Dev Biol. 2018 Jan 15;433(2):132-143. doi: 10.1016/j.ydbio.2017.09.028. Epub 2017 Dec 25.
4
Transplantation of photoreceptors into the degenerative retina: Current state and future perspectives.将光感受器移植到退行性视网膜中:现状与未来展望。
Prog Retin Eye Res. 2019 Mar;69:1-37. doi: 10.1016/j.preteyeres.2018.11.001. Epub 2018 Nov 13.
5
Stem Cell-based Treatment Strategies for Degenerative Diseases of the Retina.基于干细胞的视网膜退行性疾病治疗策略。
Curr Stem Cell Res Ther. 2022;17(3):214-225. doi: 10.2174/1574888X16666210804112104.
6
Human pluripotent stem cells: A toolbox to understand and treat retinal degeneration.人多能干细胞:理解和治疗视网膜变性的工具箱。
Mol Cell Neurosci. 2020 Sep;107:103523. doi: 10.1016/j.mcn.2020.103523. Epub 2020 Jul 4.
7
Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease.基于光感受器细胞的退行性视网膜疾病治疗的最新进展
Stem Cells Transl Med. 2024 Apr 15;13(4):332-345. doi: 10.1093/stcltm/szae005.
8
Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach.黄斑变性和视网膜色素变性中的光感受器细胞替代:基于多能干细胞的方法。
Prog Retin Eye Res. 2019 Jul;71:1-25. doi: 10.1016/j.preteyeres.2019.03.001. Epub 2019 Mar 16.
9
Stem cells in clinical trials for treatment of retinal degeneration.用于治疗视网膜变性的干细胞临床试验
Expert Opin Biol Ther. 2016;16(1):7-14. doi: 10.1517/14712598.2016.1093110. Epub 2015 Sep 28.
10
Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.基于细胞的视网膜疾病疗法:临床试验和直接面向消费者的“细胞疗法”诊所综述。
Stem Cell Res Ther. 2021 Oct 11;12(1):538. doi: 10.1186/s13287-021-02546-9.

引用本文的文献

1
Gene and Stem Cell-Based Therapies for Retinal Degenerative Diseases: Update, Challenges, and Future Directions.基于基因和干细胞的视网膜退行性疾病治疗:最新进展、挑战与未来方向
Stem Cell Rev Rep. 2025 Jul 17. doi: 10.1007/s12015-025-10927-3.
2
Exploring Stem-Cell-Based Therapies for Retinal Regeneration.探索基于干细胞的视网膜再生疗法。
Life (Basel). 2024 May 23;14(6):668. doi: 10.3390/life14060668.
3
Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration.迈向基于干细胞/祖细胞的视网膜变性治疗方法

本文引用的文献

1
Cell-Based Therapy for Retinal Disease: The New Frontier.基于细胞的视网膜疾病治疗:新前沿。
Methods Mol Biol. 2019;1834:367-381. doi: 10.1007/978-1-4939-8669-9_23.
2
Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.简明综述:接受未经证实的干细胞干预治疗的患者报告不良事件的综合分析。
Stem Cells Transl Med. 2018 Sep;7(9):676-685. doi: 10.1002/sctm.17-0282. Epub 2018 Jul 31.
3
Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.
Stem Cell Rev Rep. 2024 Aug;20(6):1459-1479. doi: 10.1007/s12015-024-10740-4. Epub 2024 May 29.
4
Neural Cells for Neurodegenerative Diseases in Clinical Trials.临床试验中的神经退行性疾病神经细胞
Stem Cells Transl Med. 2023 Aug 16;12(8):510-526. doi: 10.1093/stcltm/szad041.
5
Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.人诱导多能干细胞衍生的视网膜色素上皮细胞,为年龄相关性黄斑变性的细胞治疗提供了新的前景。
Stem Cell Res Ther. 2022 May 26;13(1):217. doi: 10.1186/s13287-022-02894-0.
6
Induction of Human Umbilical Mesenchymal Stem Cell Differentiation Into Retinal Pigment Epithelial Cells Using a Transwell-Based Co-culture System.使用基于 Transwell 的共培养系统诱导人脐带间充质干细胞向视网膜色素上皮细胞分化。
Cell Transplant. 2022 Jan-Dec;31:9636897221085901. doi: 10.1177/09636897221085901.
7
Targeted next-generation sequencing identifies ABCA4 mutations in Chinese families with childhood-onset and adult-onset Stargardt disease.靶向下一代测序鉴定中国早发性和晚发性青少年型黄斑营养不良家系中的 ABCA4 突变。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20203497.
8
Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy.在患有Stargardt型黄斑营养不良的患者中玻璃体内注射含有CD34+细胞的骨髓单个核细胞组分(BMMF)
Stem Cells Int. 2020 Dec 10;2020:8828256. doi: 10.1155/2020/8828256. eCollection 2020.
人胚胎干细胞源性视网膜色素上皮细胞移植治疗黄斑变性。
Ophthalmology. 2018 Nov;125(11):1765-1775. doi: 10.1016/j.ophtha.2018.04.037. Epub 2018 Jun 5.
4
Stem Cell Treatment in Retinal Diseases: Recent Developments.视网膜疾病的干细胞治疗:最新进展
Turk J Ophthalmol. 2018 Feb;48(1):33-38. doi: 10.4274/tjo.89972. Epub 2018 Feb 23.
5
Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.胚胎干细胞源性视网膜色素上皮贴片中年龄相关性黄斑变性的 1 期临床研究。
Nat Biotechnol. 2018 Apr;36(4):328-337. doi: 10.1038/nbt.4114. Epub 2018 Mar 19.
6
Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients.人视网膜祖细胞移植治疗色素性视网膜炎患者的长期安全性。
Stem Cell Res Ther. 2017 Sep 29;8(1):209. doi: 10.1186/s13287-017-0661-8.
7
Intravitreal use of bone marrow mononuclear fraction containing CD34 stem cells in patients with atrophic age-related macular degeneration.在萎缩性年龄相关性黄斑变性患者中玻璃体内使用含CD34干细胞的骨髓单个核细胞组分。
Clin Ophthalmol. 2017 May 19;11:931-938. doi: 10.2147/OPTH.S133502. eCollection 2017.
8
Integration of Subretinal Suspension Transplants of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in a Large-Eyed Model of Geographic Atrophy.人胚胎干细胞来源的视网膜色素上皮细胞视网膜下悬浮移植在地图样萎缩大眼模型中的整合
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1314-1322. doi: 10.1167/iovs.16-20738.
9
Advances in bone marrow stem cell therapy for retinal dysfunction.用于视网膜功能障碍的骨髓干细胞疗法的进展
Prog Retin Eye Res. 2017 Jan;56:148-165. doi: 10.1016/j.preteyeres.2016.10.002. Epub 2016 Oct 23.
10
Efficacy and Safety of Human Retinal Progenitor Cells.人类视网膜祖细胞的疗效与安全性
Transl Vis Sci Technol. 2016 Jul 19;5(4):6. doi: 10.1167/tvst.5.4.6. eCollection 2016 Jul.